26 June 2025 Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal ...

Bayer appoints new head of IP ...

French biopharma giant overturns German rival’s patent at the European Patent Office | Revocation based on insufficient ...

This session brings together experts from Choate, Radius Health, and Syros Pharmaceuticals to examine the current policy ...

11 January 2022 Alexion, AstraZeneca’s rare disease group, has entered into an exclusive licensing agreement with Neurimmune ...

Trio have worked together for several years at different firms, bringing decades of experience in medical devices, robotics, ...

Appeals board overturns previous decision and revokes patent on treatment worth $2bn in 2024 | Teva and Generics UK ...

Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major changes to European law | Case returns to lower court for novelty and ...

David Gindler of Orrick discusses the US Supreme Court’s ruling in Amgen v. Sanofi and what it means for ongoing Section 112 ...

Regeneron files motion to disqualify firm from patent and antitrust dispute | Motion cites conflict of interest due to ...

Despite efforts to harmonise, the Unified Patent Court’s local divisions and Court of Appeal have signalled a divergence over ...

4 February 2025 Federal Circuit upholds preliminary injunctions blocking highly similar versions of Eylea | Samsung Biopeis ...